Summary
In this article, published in The Pharmaceutical Journal, Emma Wilkinson reflects on the findings and recommendations of the Review of patient safety across the health and care landscape chaired by Dr Penny Dash. She focuses on its proposals to streamline oversight and reduce duplication around the patient voice, specifically plans to abolish Healthwatch England and bring its functions in-house within a new Patient Experience directorate in the Department of Health and Social Care.
The Dash review and its impact on the future of patient advocacy (27 August 2025)
https://pharmaceutical-journal.com/article/feature/the-dash-review-and-its-impact-on-the-future-of-patient-advocacy
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now